Pharmaceuticals


U.S. Food and Drug Administration
National

FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species

- by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved Solensia (frunevetmab injection), the first treatment for the control of pain associated with osteoarthritis in cats and the first …

FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species Read More


coronavirus
Health / Medical / National

Federal Government Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine

- by MyChesCo

WASHINGTON, D.C. — The Biden Administration announced it recently secured 10 million treatment courses of Pfizer’s promising COVID-19 oral antiviral drug, contingent on emergency use authorization (EUA) or approval from …

Federal Government Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine Read More
Melior Pharmaceutical
Business

Melior Pharmaceuticals Announces Execution of License Agreement for Armesocarb by Adhera Therapeutics

- by MyChesCo

EXTON, PA — Melior Pharmaceuticals announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . (OTCPK: ATRX) for Melior’s Parkinson’s disease (PD) candidate, MLR-1019 (armesocarb).

Melior Pharmaceuticals Announces Execution of License Agreement for Armesocarb by Adhera Therapeutics Read More

Prescription
Pennsylvania

Attorney General Shapiro Announces $26 Billion Agreements with Opioid Distributors/Manufacturer

- by MyChesCo

HARRISBURG, PA — Attorney General Josh Shapiro yesterday announced a historic agreement with Cardinal, McKesson, and AmerisourceBergen—the nation’s three major pharmaceutical distributors—and Johnson & Johnson, which manufactured and marketed opioids, …

Attorney General Shapiro Announces $26 Billion Agreements with Opioid Distributors/Manufacturer Read More